# HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

> **NCT01103505** · NA · COMPLETED · sponsor: **Notal Vision Ltd.** · enrollment: 1520 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DIAGNOSTIC_TEST:** ForeseeHome AMD Monitoring Device

## Key facts

- **NCT ID:** NCT01103505
- **Lead sponsor:** Notal Vision Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 1520 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103505, "HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01103505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*